A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment.

Meredith C HendersonMichael SilverQuynh TranElias E LetsiosRao MulpuriDavid E ReeseAna P LourencoJoshua LaBaerKaren S AndersonJosie AlpersCarrie CostantiniNitin RohatgiHaythem Y AliKaren BakerDonald W NorthfeltKarthik GhoshStephen R GrobmyerWinnie PolenJudith K Wolf

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)

Videssa Breast combines serum biomarkers with clinical patient characteristics to provide clinicians with additional information for patients with indeterminate breast imaging results, potentially reducing false-positive breast biopsies.

Keyphrases

high resolution
polycystic ovary syndrome
high throughput
healthcare
metabolic syndrome
mass spectrometry
young adults
photodynamic therapy
childhood cancer